DE vs TMO: Which Is the Better Buy?
Side-by-side comparison of Deere & Company and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Deere & Company · Industrials
$578.39
+22.4% upside to fair value
Grade C
VS
Thermo Fisher Scientific Inc. · Healthcare
$462.60
+10.1% upside to fair value
Grade B
QuantHub Verdict
DE has more upside to fair value
(+22.4%).
TMO trades at a lower forward P/E
(25.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DE |
TMO |
| Current Price |
$578.39 |
$462.60 |
| Fair Value Estimate |
$708.19 |
$509.20 |
| Upside to Fair Value |
+22.4%
|
+10.1%
|
| Market Cap |
$156.2B |
$171.9B |
| Forward P/E |
32.5x
|
25.1x
|
| EV / EBITDA |
18.4x
|
19.0x
|
| Price / Sales |
3.4x
|
3.8x
|
| Price / FCF |
43.7x
|
25.5x
|
| Revenue Growth YoY |
+16.3%
|
+6.2%
|
| Gross Margin |
35.6%
|
39.4%
|
| Operating Margin |
18.5%
|
17.8%
|
| Return on Equity |
18.9%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
2.29%
|
3.92%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Deere & Company is a leading manufacturer of agricultural, construction, and forestry machinery, with a strong position in production and precision agriculture, small agriculture and turf, and construction and forestry segments. The company benefits from a durable competitive moat driven by its brand, intangible assets, and switching costs, supported by a CEO with deep institutional knowledge and…
Thermo Fisher Scientific Inc. operates in the healthcare sector, specializing in medical diagnostics and research tools across four main segments: Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company demonstrates medium business quality with steady revenue growth of 6.2% and earnings growth of 9.6% in the most recent q…
Accumulation Zones
| Metric |
DE |
TMO |
| Zone Low |
$531.14 |
$381.90 |
| Zone High |
$601.96 |
$432.82 |
| In Buy Zone? |
Yes
|
No
|